ATE278701T1 - Malto-oligosaccharide und deren verwendung - Google Patents

Malto-oligosaccharide und deren verwendung

Info

Publication number
ATE278701T1
ATE278701T1 AT01934498T AT01934498T ATE278701T1 AT E278701 T1 ATE278701 T1 AT E278701T1 AT 01934498 T AT01934498 T AT 01934498T AT 01934498 T AT01934498 T AT 01934498T AT E278701 T1 ATE278701 T1 AT E278701T1
Authority
AT
Austria
Prior art keywords
hyperglycemia
alpha
prophylactic
diabetes
integer
Prior art date
Application number
AT01934498T
Other languages
English (en)
Inventor
Riichiro Uchida
Ayako Nasu
Yukihiko Iwai
Takao Someya
Koichiro Tobe
Original Assignee
Kikkoman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kikkoman Corp filed Critical Kikkoman Corp
Application granted granted Critical
Publication of ATE278701T1 publication Critical patent/ATE278701T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/02—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Seasonings (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT01934498T 2000-06-06 2001-06-01 Malto-oligosaccharide und deren verwendung ATE278701T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000168363 2000-06-06
PCT/JP2001/004653 WO2001094367A1 (fr) 2000-06-06 2001-06-01 Derives de malto-oligosaccharide et utilisation correspondante

Publications (1)

Publication Number Publication Date
ATE278701T1 true ATE278701T1 (de) 2004-10-15

Family

ID=18671377

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01934498T ATE278701T1 (de) 2000-06-06 2001-06-01 Malto-oligosaccharide und deren verwendung

Country Status (7)

Country Link
US (1) US6939858B2 (de)
EP (1) EP1291349B1 (de)
JP (1) JP4373671B2 (de)
AT (1) ATE278701T1 (de)
AU (1) AU2001260695A1 (de)
DE (1) DE60106246T2 (de)
WO (1) WO2001094367A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101050981B1 (ko) * 2003-01-30 2011-07-21 상꾜 가부시키가이샤 올리고당 유도체
JP2006063074A (ja) * 2004-07-29 2006-03-09 Sankyo Co Ltd 糖尿病治療薬を含有する医薬組成物
TW200612968A (en) * 2004-07-29 2006-05-01 Sankyo Co Oligosaccharide derivatives containing with heterocycle
TW200608967A (en) * 2004-07-29 2006-03-16 Sankyo Co Pharmaceutical compositions containing with diabetic agent

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2064527B (en) * 1979-12-08 1984-05-02 Nippon Shinyaku Co Ltd Moranoline derivatives and process for preparation thereof
JP3909735B2 (ja) * 1999-02-22 2007-04-25 キッコーマン株式会社 マルトオリゴ糖誘導体及びその用途

Also Published As

Publication number Publication date
JP4373671B2 (ja) 2009-11-25
US6939858B2 (en) 2005-09-06
WO2001094367A1 (fr) 2001-12-13
DE60106246T2 (de) 2005-03-10
EP1291349A1 (de) 2003-03-12
EP1291349B1 (de) 2004-10-06
DE60106246D1 (de) 2004-11-11
US20040006046A1 (en) 2004-01-08
EP1291349A4 (de) 2003-08-27
AU2001260695A1 (en) 2001-12-17

Similar Documents

Publication Publication Date Title
NO20020968L (no) Glukopyranosyloksypyrazolderivater, medisinske sammensetninger inneholdende det samme og intermediater forfremstillingen derav
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
ATE202346T1 (de) Benzofuran derivate und ihre verwendung als inhibitoren der knochenresorption
CA2336412A1 (en) Medicament for treatment of diabetes
ES2098947T3 (es) Derivados de beta,beta-dimetil-4-piperidinoetanamina como inhibidores de la biosintesis del colesterol.
DE69215694D1 (de) Benzamid-derivate
NO20026014L (no) Vitamin D-derivater
SE0201837D0 (sv) Chemical compounds
ATE275572T1 (de) Malto-oligosaccharid-derivate und ihre anwendungen
ATE278701T1 (de) Malto-oligosaccharide und deren verwendung
NO20015666L (no) Umiddelbar frigivelses medisinske sammensetninger for oral anvendelse
DK0911026T3 (da) Creatinderivater for astma
PT1218401E (pt) 4-benzilaminoquinolinas conjugadas com acido biliar e seus heterociclicos metodos de sua producao medicamentos contendo estes compostos e sua aplicacao
DE69413831D1 (de) Phenoxyphenylcyclopentenyl-hydroxyharnstoffe
DE69907387D1 (de) Verwendung von Hydantoin-Derivaten zur Herstellung eines Medikaments zur Behandlung von refraktärer Vasculitis.
PE20030236A1 (es) Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados
EA200600022A1 (ru) Применение производных бицикло [2.2.1] гептана для приготовления нейропротекторных фармацевтических композиций
DE69414396D1 (de) Acylphenylglycin-derivat und dieses als aktivbestandteil enthaltendes vorbeugungs -und heilmittel gegen durch erhöhte collagenaseaktivität verursachte krankheiten
DE69312512D1 (de) Etoposid-derivate, ihre herstellung, ihre verwendung als medikament und ihre verwendung zur herstellung eines antikrebsmittels
DE60104589D1 (de) Therapeutisches Mittel zur Behandlung von Dermatitis
SG146685A1 (en) Dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them
PE20030438A1 (es) Medicamento que comprende un derivado de eritromicina como agente antituberculoso

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties